SEC Comment Letter for Altimmune, Inc. (ALT) (CIK 0001326190) (ALT) — Mar 1, 2010

Altimmune, Inc. (ALT) (CIK 0001326190)
Date: March 1, 2010 · CIK: 0001326190 · Accession: 0000000000-10-011363

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-32587

Date

March 1, 2010

Author

Joel Parker

Form

UPLOAD

Company

Altimmune, Inc. (ALT) (CIK 0001326190)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 March 1, 2010 Charles A. Reinhart III Chief Financial Officer PharmAthene, Inc. One Park Place, Suite 450 Annapolis, MD

Re: PharmAthene, Inc. Form 10-K for the Year Ended December 31, 2008 Form 10-Q for the Period Ended September 30, 2009 File No. 001-32587

Dear Mr. Reinhart:

We have completed our review of your Forms 10-K and 10-Q and have no further comments at this time. S i n c e r e l y , J o e l P a r k e r A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

Via Facsimile and U.S. Mail
Mail Stop 4720

        March 1, 2010

Charles A. Reinhart III
Chief Financial Officer
PharmAthene, Inc.
One Park Place,
Suite 450
Annapolis, MD

 Re: PharmAthene, Inc.
  Form 10-K for the Year Ended December 31, 2008
  Form 10-Q for the Period Ended September 30, 2009
  File No. 001-32587

Dear Mr. Reinhart:

 We have completed our review of your Forms 10-K and 10-Q and have no further
comments at this time.
        S i n c e r e l y ,
           J o e l  P a r k e r          A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io